Biblio
Journal Article
de Langen AJohannes, Johnson ML, Mazières J, Dingemans A-MC, Mountzios G, Pless M, Wolf J, Schuler M, Lena H, Skoulidis F, et al. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS mutation: a randomised, open-label, phase 3 trial. Lancet. 2023.